Morphea and Extragenital Lichen Sclerosus et Atrophicus After Influenza Vaccination.

1. Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol. 2007;46:895--904. 2. Schaefer I, Augustin M, Spehr C, Reusch M, Kornek T. Prevalence and risk factors of actinic keratoses in Germany----analysis of multisource data. J Eur Acad Dermatol Venereol. 2014;28:309--13. 3. Naldi L, Chatenoud L, Piccitto R, Colombo P, Placchesi EB, La Vecchia C, et al. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: results from the Prevalence of Actinic Keratoses Italian Study, 2003--2004. Arch Dermatol. 2006;142:722--6. 4. Eder J, Prillinger K, Korn A, Geroldinger A, Trautinger F. Prevalence of actinic keratosis among dermatology outpatients in Austria. Br J Dermatol. 2014. 5. Flohil SC, van der Leest RJT, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol. 2013;133:1971--8. 6. Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol. 2000;142:1154--9. 7. Costa C, Scalvenzi M, Ayala F, Fabbrocini G, Monfrecola G. How to treat actinic keratosis? An update. J Dermatol Case Rep. 2015;9:29--35. 8. Chetty P, Choi F, Mitchell T. Primary care review of actinic keratosis and its therapeutic options: a global perspective. Dermatol Ther. 2015;5:19--35. 9. Ferrándiz C, Plazas MJ, Sabaté M, Palomino R, EPIQA Study Group. Prevalence of actinic keratosis among dermatology outpatients in Spain. Actas Dermosifiliogr. 2016. 10. Youl PH, Janda M, Aitken JF, Del Mar CB, Whiteman DC, Baade PD. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice. Br J Dermatol. 2011;165:35--43.